Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2091
Gene Symbol: FBL
FBL
0.100 Biomarker disease BEFREE Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C. 31831303 2019
Entrez Id: 2091
Gene Symbol: FBL
FBL
0.100 Biomarker disease BEFREE FIB-4 and APRI scores for predicting severe fibrosis in chronic hepatitis C - a developing country's perspective in DAA era. 31829993 2018
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.100 Biomarker disease BEFREE PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression. 31793339 2019
Entrez Id: 174
Gene Symbol: AFP
AFP
0.100 Biomarker disease BEFREE Direct acting antiviral (DAA) treatments may reduce the elevated α fetoprotein (AFP), but data on how these treatments affect elevated AFP in patients with chronic hepatitis C (CHC) remain insufficient. 31655955 2019
Entrez Id: 2638
Gene Symbol: GC
GC
0.020 GeneticVariation disease BEFREE Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients. 31600151 2017
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.070 GeneticVariation disease BEFREE Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. 31565578 2019
Entrez Id: 2091
Gene Symbol: FBL
FBL
0.100 Biomarker disease BEFREE Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients. 31558693 2019
Entrez Id: 80339
Gene Symbol: PNPLA3
PNPLA3
0.100 GeneticVariation disease BEFREE PNPLA3 rs738409 minor allele c.444G represents a risk factor for liver steatosis and fibrosis progression also in chronic hepatitis C (HCV). 31527889 2019
Entrez Id: 101180976
Gene Symbol: IFNL4
IFNL4
0.200 GeneticVariation disease BEFREE We investigated longitudinal changes in metabolic and inflammatory outcomes in chronic hepatitis C (CHC) patients: low-density lipoprotein (LDL), high-density lipoprotein, triglycerides, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) using a general linear model for repeated measurements at 5 clinical time points and by human immunodeficiency virus (HIV) coinfection and IFNL4 genotype. 31504644 2020
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.100 Biomarker disease BEFREE We investigated longitudinal changes in metabolic and inflammatory outcomes in chronic hepatitis C (CHC) patients: low-density lipoprotein (LDL), high-density lipoprotein, triglycerides, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) using a general linear model for repeated measurements at 5 clinical time points and by human immunodeficiency virus (HIV) coinfection and IFNL4 genotype. 31504644 2020
Entrez Id: 3627
Gene Symbol: CXCL10
CXCL10
0.100 Biomarker disease BEFREE Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? 31485460 2019
Entrez Id: 3965
Gene Symbol: LGALS9
LGALS9
0.030 Biomarker disease BEFREE The objective of this study was to determine whether Galectin-9 and other serum proteins are associated with active disease in AIH patients.We enrolled 77 Japanese patients with well-documented AIH who were identified from the National Hospital Organization-AIH-liver-network database, as well as 32 patients with chronic hepatitis C (CHC), 27 patients with SLE, and 17 healthy control subjects. 31464928 2019
Entrez Id: 3447
Gene Symbol: IFNA13
IFNA13
0.100 Biomarker disease BEFREE In HCV<sup>+</sup>(F4) individuals, nearly all CD8<sup>+</sup> T-cell subsets had an elevated proportion of perforin<sup>+</sup> cells while naïve cells had increased proportions of IFN-γ<sup>+</sup> and CD107<sup>+</sup> cells. 31456810 2019
Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1
0.100 Biomarker disease BEFREE In HCV<sup>+</sup>(F4) individuals, nearly all CD8<sup>+</sup> T-cell subsets had an elevated proportion of perforin<sup>+</sup> cells while naïve cells had increased proportions of IFN-γ<sup>+</sup> and CD107<sup>+</sup> cells. 31456810 2019
Entrez Id: 9935
Gene Symbol: MAFB
MAFB
0.010 Biomarker disease BEFREE Transcription Factor MafB Suppresses Type I Interferon Production by CD14<sup>+</sup> Monocytes in Patients With Chronic Hepatitis C. 31447817 2019
Entrez Id: 619501
Gene Symbol: HCC
HCC
0.010 Biomarker disease BEFREE This study aimed to evaluate survival outcomes in patients with non-B non-C hepatocellular carcinoma (NBNC-HCC) with reference to patients with HCC achieving sustained virological response (SVR) by preoperative interferon (IFN) treatment for chronic hepatitis C. 31385170 2019
Entrez Id: 406991
Gene Symbol: MIR21
MIR21
0.010 Biomarker disease BEFREE Relation between microRNA-21, transforming growth factor β and response to treatment among chronic hepatitis C patients. 31368531 2019
Entrez Id: 3704
Gene Symbol: ITPA
ITPA
0.200 GeneticVariation disease BEFREE Polymorphisms of inosine triphosphate pyrophosphatase (rs1127354 and rs6051702) and interferon lambda 4 (IFLN4) (rs12979860) are indicators of anemia and/or sustained virological response (SVR) in patients with chronic hepatitis C on ribavirin/interferon. 31359493 2020
Entrez Id: 282617
Gene Symbol: IFNL3
IFNL3
0.200 GeneticVariation disease BEFREE Polymorphisms of inosine triphosphate pyrophosphatase (rs1127354 and rs6051702) and interferon lambda 4 (IFLN4) (rs12979860) are indicators of anemia and/or sustained virological response (SVR) in patients with chronic hepatitis C on ribavirin/interferon. 31359493 2020
Entrez Id: 101180976
Gene Symbol: IFNL4
IFNL4
0.200 GeneticVariation disease BEFREE Polymorphisms of inosine triphosphate pyrophosphatase (rs1127354 and rs6051702) and interferon lambda 4 (IFLN4) (rs12979860) are indicators of anemia and/or sustained virological response (SVR) in patients with chronic hepatitis C on ribavirin/interferon. 31359493 2020
Entrez Id: 4968
Gene Symbol: OGG1
OGG1
0.020 GeneticVariation disease BEFREE Urinary 8-hydroxydeoxyguanosine in relation to XRCC1 rs25487 G/A (Arg399Gln) and OGG1 rs1052133 C/G (Ser326Cys) DNA repair genes polymorphisms in patients with chronic hepatitis C and related hepatocellular carcinoma. 31354343 2019
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.100 GeneticVariation disease BEFREE Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C. 31291311 2019
Entrez Id: 10855
Gene Symbol: HPSE
HPSE
0.010 GeneticVariation disease BEFREE HPA polymorphism has been associated with HCV presence and fibrosis progression in chronic hepatitis C. However, it is unknown if there is an association between HPA-1 polymorphism and hepatocellular carcinoma (HCC). 31271612 2019
Entrez Id: 25984
Gene Symbol: KRT23
KRT23
0.010 AlteredExpression disease BEFREE In this study, we investigated KRT23 mRNA levels in datasets from liver biopsies of chronic hepatitis C (CHC) patients and in primary human hepatocytes experimentally infected with HCV, in addition to hepatoma cells. 31216713 2019
Entrez Id: 5806
Gene Symbol: PTX3
PTX3
0.020 AlteredExpression disease BEFREE PTX3 associations with biochemical and histological parameters of inflammatory activity and fibrosis were investigated in 138 patients with chronic viral hepatitis C (HCV) before antiviral treatment. 31061822 2019